DR. DINESH PENDHARKAR,  MD, PhD, FASCO

(Fellow American Society of Clinical Oncology)

Contact No: 91-9987736665;         Email: drpendharkar@gmail.com

Director and Head

Medical Oncology, Haemato-Oncology and Bone Marrow Transplantation

Sarvodaya Cancer Institute

Faridabad,Delhi NCR

India

IMPORTANT MILESTONES

FASCO- Fellow American Society of Clinical Oncology

Pioneer to introduce and establish Speciality of Medical Oncology in India in practice.

Performed First Bone Marrow Transplantation in rural setup (Indore)1998.

World recognised practice changing research on the management of Chemotherapy induced toxicity-Hand Foot Syndrome-use of urea containing ointment

Recognised leader in Global Oncology – professional empowerment and service

Established  Interntationally recognised ,Novel Healthcare Delivery Model of expanding cancer care at scale, to more than 150 districts of India (Key Note -Harvard-MIT2017).

Impactful PUBLICATIONS

• Management of Hand Foot syndrome using urea ointment (Novel and effective management of capecitabine induced hand foot syndrome Proccedings ASCO, volume 23, PP 3308, 2004)
• Empowering alternate oncology workforce, (In-Thinking differently in global health in oncology……) Education Book, ASCO  2017,pp. 416-425 Multiple publications , book chapters, mainly Indian Journals and ASCO abstracts

Organization: American Society of Clinical Oncology

Fellow American Society of Clinical Oncology

Past Chair: International Affairs Committee 2017

Past Chair: Working Committee , MCMC(Multidisciplinary Cancer Management Course) ASCO2013-2015

Member-2004-2006 ,2016-18, International affairs committee American Society of Clinical Oncology (ASCO)

Member IDEA working group

Other Engagements with ASCO

Program Director-

• First Course –Cancer Control for Primary Care ,Bhopal India March 2015
• MCMC Course-ASCO- Yerevan Armenia May 2014
• Course Molecular Oncology with ASCO support New Delhi 2007
• BEST of ASCO ,2011, Hyderabad India

Faculty-

• MCMC Course- Kathmandu Nepal
• MCMC Course Eldoret Kenya 2012
• MCMC Course Eldoret Kenya 2013
• MCMC Course  Chandigarh India 2014
• MCMC Bhutan 2018

CURRENT    POSITIONS    HELD-

Director, Sarvodaya Cancer Institute, Faridabad                                                        Since Jan 2016-Till date

Director - Dept of Medical Oncology, Haemato-oncology, BMT                            

Board Member, Acharya Harihar Post Graduate Institute of Cancer

Cuttack , Odisha                                                                                                                  Since 2021-till date

Director, Odisha Cancer Care Foundation (Government s.8 company)                Since 2019-till date

Advisor, Karkinos Healthcare, Mumbai                                                                         Since 2022

Director, International Cancer Institute, Eldoret, Kenya                                           Since 1917

Mentor, Founder, Innovator District Cancer Care Programme Governments of

              Madhya Pradesh                                                                                                  Since  2014

              Odisha                                                                                                                    Since 2016

              Rajasthan                                                                                                               Since 2017

              Himachal Pradesh                                                                                                Since 2017

              Gujarat                                                                                                                   Since  2019

              Chhattisgarh                                                                                                         Since 2020

EXPERIENCE, Positions Held , Affiliations  

Yerevan State Medical   University,  Armenia                  Visiting Professor                                           Since, May’17-21

Kyrgyz National Oncology Center, Bishkek                      Visiting Professor                                           1992-95

Lilawati Hospital, Mumbai,  Consultant Medical Oncology                                                                 2010-2014

Batra Cancer Center, Batra Hospital and Medical Research Center, Delhi                                            Aug 00-Sep 12

Senior Consultant & Head Medical Oncology

Sitaram Bhartiya Institute of Clinical Research, Delhi                                                                           Jun’01-2009

Senior Consultant Medical Oncology-                               Hon Visiting

Northern Railway Central Hospital, Delhi                                                                                                Jun’02-Jul’09

Senior Consultant Medical Oncology-                               Hon Visiting

Maharaja Agarsen Hospital                                                                                                                          May’02-Sep’04

Senior Consultant Medical Oncology-                               Hon Visiting

Pushpawati Singhaniya Institute of Renal and Digestive Diseases                                                    May’03-2008

Senior Consultant Medical Oncology,                               Hon. Visiting

Escorts Heart Institute                                                                         Hon. Visiting                                           Jun’04-Aug’07

Senior Consultant Medical Oncology,

Rockland Hospital                                                                   Hon. Visiting                                                Jul’04-2008

Senior Consultant Medical Oncology   

Fortis Group of Hospitals                                                      Hon. Visiting                                                Jan’06-2009

Senior Consultant Medical Oncology

Cancer Care Trust & Research Foundation, Indore        Founder                                                        1989-2000

Founder Trustee & Head Medical Oncology

Choithram Hospital & Research Center, Indore              Head Med.Onco/ Professor                         Jun’87-Jul’00

Head Medical Oncology/ Hon. Associate Professor

Department of Radiotherapy Hamidia Hospital

MG Medical College, Bhopal                                                Physician, Oncology                                        Dec’85-Jun’87

Institute Rotary Cancer Hospital, Medical Oncology

All India Institute of Medical Sciences, New Delhi                                  Consultant- Pool Officer            1985-1987

Tata Memorial Hospital Mumbai, dept of Chemotherapy,                       Junior Resident              Jan 81-Sept 81

Exec, Committee Member, Asian Cellular Therapy Organisation,                        Since 2017

Japan

Visiting Professor, Consultant Oncology, National Cancer Center Tashkent,

              Uzbekistan                                                                                                            Since 2017-till date

Visiting Professor, Advisor, International Cancer Institute, Eldoret

Kenya                                                                                                                                    Since 2018-till date

Visiting Professor, Oncology, Tashkent Medical Academy, Khwarezm

Branch, Urgench ,Uzbekistan                                                                                          Since 2022 -till date

Visiting Professor, Andijan State Medical Institute, Depart. Of Oncology

Andijan, Uzbekistan                                                                                                           Since 2022-till date

Visiting Professor, Depart of Oncology, Salymbekov University, Bishkek

Kyrgyzstan                                                                                                                           Since 2022-till date

Faculty Resource, American Society of Clinical Oncology                                         Since 2007-till date

ACADEMIC CREDENTIALS

FELLOWSHIPS, TRAININGS

Registrations

• Medical Council of India  (MCI 1799)
• Delhi Medical Council   ( 18813)
• MP Medical Council  
• Kenya Medical Council (Temporary and Specialist) (0000771, 000866)
• Burundi Medical Council

Academic / Teaching  affiliations

Member Lymphoma Guidelines Committee,   ICMR-Indian Council of Medical Research

Examiner, Medical Oncology, Gujrat Cancer &Research Institute, Ahmedabad    1996-2000

Associate Editor, Indian Journal of Medical & Paediatric Oncology,                          2010-2015

Clinical Research / Trials

ICH GCP Certified trial expert

Post Graduate Diploma in Clinical Research 2006

Secrtetary  Ethics Committee (past), Batra Hospital & Research Center

Trials List

A multicenter randomized open label steady state two way crossover bioequivalence study comparing imatinib mesylate tablets 400 mg (Apotex Inc, Canada) to the reference listed drug (RLD) Gleevec, (Imatinib ) tablets, 400 mg (Novartis Pharmaceuticals USA ), in patients who are already receiving a stable daily dose of 400 mg imatinib mesylate tablets. ( CPU /IMAT/06/029).

An expanded access program of Tarceva (erlotinib) in patients with advanced stage IIIB/ IV non small cell lung cancer (NSCLC). Protocol M18109                                

A prospective, non-comparative, open- label , multicenter study to evaluate safety and efficacy of Pegfilgratim (IPL-P05) for prevention of neutropenia in patients receiving cancer chemotherapy.(IPL-IBT-PO5-05)

A phase III, controlled trial of Myocet, trastuzumab, and paclitaxel versus Trastuzumab and paclitaxel for first line therapy of metastatic breast cancer ( STM-01-102)

A non-comparative multicenter, open lable study to evaluate the safety, tolerability and efficacy of caspofungin acetate (MK-0991) as empirical therapy in Indian adults with persistent fever and neutropenia.

 (CASCAN  Trial-  registration trial)

A multi- centric, open label, phase III clinical trial to evaluate the safety and efficacy of filgrastim (Zenotech) in cancer patients with grade 3 or 4 chemotherapy induced neutropenia. ( Zen-01/2004)

Trials received (DCGI site approved )but could not be done due to IRB issues

A novel aza-anthracendione versus other chemotherapeutic agents for third line single agent treatment of patients with relapsed aggressive Non Hodgkins Lymphoma : A randomized controlled phase III comparative trial. ( PIX301)

Efficacy and safety of XM01 compared to placebo in anemic patients with low grade non-Hodgkin’s lymphoma,chronic lymphocytic leukemia o multiple myeloma receiving anticancer therapy (A multinational, multicenter, randomized placeo controlled ,double-blind, parallel group phase III study). (Biochemix study No. XM01-23, Endract No. 2005-001422-89)

Efficacy and safety of XM01 compared to placebo in patients with solid tumors or non-myeloid haematological tumors receiving nonplatinum chemotherapy. (A multinational, multicenter, randomized placeo controlled , double-blind, parallel group phase III study). (Biochemix study No. XM01-22, Endract No. 2005-001421-28)

Efficacy and safety of XM01 compared to placebo and epoetin beta in patients with solid tumors receiving platinum containing chemotherapy. A multinational, multicentric, randomized placebo and active controlled, double blind parallel group phase III study. (Biogenerix study No. XM01-21. Endract No. 2005-001419-23).

Phase II study of SLIT™ Cisplatin by inhalation in the treatment of patients with bronchoalveolar carcinoma. (TR01-202)

External Audit

US FDA Audit

G-csf trial audit by another CRO

Title of Research works Completed (Data Presented at various meetings)

Mangement of capecitabine induced hand foot syndrome

Empowerment of alternate oncology workforce

Health system strengthening using technomentoring

Development  & implementation science of district cancer programme

Development and implementation of state wide palliative care programme

NGS studies in Uzzbekistan population

Knowledge,Attitude,Practice in sicl;e cell disease

Quality of life in SCD

HbF levels in SCD

Combining Nimotuzumab with chemotherapy- toxicity study

Loading Dose Ibandronate for acute pain relief in metastatic bone diseases

EPO & Ferritin levels in patients undergoing chemotherapy

Anemia in patients undergoing radiotherapy

Higher dose intensity with weekly docetaxel

Shortened premedication for taxanes

LDH isoenzymes in malignancy

Iphosphamide and Fluracil- Toxicity Study

Methodology (Planning & Designing) of Mass Public Educational Campaigns

Clinical Relevance of  the WHO Classification For Non-Hodgkin’s Lymphomas

Patterns of Relapse After radiotherapy and Its Management in Non-Hodgkin’s Lymphoma

Role of High Dose L-Asparaginase in the Treatment of Lymphoma

Chemotherapy of Non-Hodgkin’s Lymphoma

Second Malignancies in Hodgkin’s Disease

Tobacco Usage Prevalence in Different Areas of M.P.

Pan- Masala Usage Prevalence in Different Areas of M.P.

CAREER HIGHLIGHTS

EXPERIENCE, Positions Held , Affiliations  

Yerevan State Medical   University,  Armenia                  Visiting Professor                                           Since, May’17-21

Kyrgyz National Oncology Center, Bishkek                      Visiting Professor                                           1992-95

Lilawati Hospital, Mumbai,  Consultant Medical Oncology                                                                 2010-2014

Batra Cancer Center, Batra Hospital and Medical Research Center, Delhi                                            Aug 00-Sep 12

Senior Consultant & Head Medical Oncology

Sitaram Bhartiya Institute of Clinical Research, Delhi                                                                           Jun’01-2009

Senior Consultant Medical Oncology-                               Hon Visiting

Northern Railway Central Hospital, Delhi                                                                                                Jun’02-Jul’09

Senior Consultant Medical Oncology-                               Hon Visiting

Maharaja Agarsen Hospital                                                                                                                          May’02-Sep’04

Senior Consultant Medical Oncology-                               Hon Visiting

Pushpawati Singhaniya Institute of Renal and Digestive Diseases                                                    May’03-2008

Senior Consultant Medical Oncology,                               Hon. Visiting

Escorts Heart Institute                                                                         Hon. Visiting                                            Jun’04-Aug’07

Senior Consultant Medical Oncology,

Rockland Hospital                                                                   Hon. Visiting                                                Jul’04-2008

Senior Consultant Medical Oncology   

Fortis Group of Hospitals                                                      Hon. Visiting                                                Jan’06-2009

Senior Consultant Medical Oncology

Cancer Care Trust & Research Foundation, Indore        Founder                                                        1989-2000

Founder Trustee & Head Medical Oncology

Choithram Hospital & Research Center, Indore              Head Med.Onco/ Professor                         Jun’87-Jul’00

Head Medical Oncology/ Hon. Associate Professor

Department of Radiotherapy Hamidia Hospital

MG Medical College, Bhopal                                                Physician, Oncology                                        Dec’85-Jun’87

Institute Rotary Cancer Hospital, Medical Oncology

All India Institute of Medical Sciences, New Delhi                                  Consultant- Pool Officer            1985-1987

Tata Memorial Hospital Mumbai, dept of Chemotherapy,                       Junior Resident              Jan 81-Sept 81

Recognized with various Awards & Facilitations Like:

• Life Time Achievement Award , Indian Society of Oncology 2022

• S H Advani Oration- Jaipur 2018
• Special Appreciation Award, Govt of Odisha 2017

• SK Mukherjee-Physician Recognition Award, Indore 2016
• Physician Recognition Award- Govt of Madhya Pradesh, 2016
• Marqui’s Who’s Who in Medicine and Healthcare 2006-2007
• Oration-      Indian Society of Medical & Paediatric Oncology- 2006
• Distinguished Doctor Award- DMA 2005
• SIOP Award 2002 (international Society of Paediatric Oncology) (Co-author with members of National Training Project)
• Pt. P.K.Shankhdhar Memorial Oration ,2002, Lucknow.
• Study Grant –PhD Medical Oncology (Indo-USSR)
• Study Grant –MD (Indo-USSR)
• Travel Grant Council of Scientific & Industrial Research, Govt. of India
• Travel Grant Department of Science & Technology, Govt. of India
• Bone Marrow Transplant Training Fellowship- Pharmacia –Upjohn, Hong Kong
• Fellowship for Training in Laser (at Academy of Medical Sciences, Moscow) by Department of Science & Technology , Govt. of India
• Financial Awards from Jal Trust Indore, Lions’ Club of Indore East, Win Medicare, Delhi Cancer Foundation.
• Winner Computer Quiz (Farm Italia) at International Cancer Congress Hamburg Germany.
• Man of the Year, JAYCEE Central Indore

AFFILIATIONS AND MEMBERSHIPS RELATED TO ONCOLOGY & MEDICINE

• Active Member-American Society of Clinical Oncology
• Active Member European Society of Medical Oncology
• Asian Cellular Therapy Organisation
• Life Member- Indian Society of Medical & Paediatric Oncology
• Life Member-Indian Society of Oncology
• Life Member-ICON-Indian Cooperative Oncology Network
• Life  Member- Paediatric Haematology-Oncology Chapter, Indian Academy of Paediatrics
• Life Member-Indian Society of Haematology & Transfusion Medicine
• Life Member-Indian Medical Association
• Life Member-IMA College of General Practitioners (MP338/LM1765)
• Life Member-Indian Laser Association

ENGAGEMENTS WITH PROFESSIONAL BODIES LIKE:

American Society of Clinical Oncology , International Affairs Committee              Chairman           2017

American Society of Clinical Oncology, Multidisciplinary Cancer

Management Course , MCMC                                                                                         Chairman           2013-15

American Society of Clinical Oncology, Idea Working Group                                Chairman           2007-8

Asian Cellular Therapy Organisation, Exec,Committee                                           Member             2017-22              

Indian Society of Oncology                                                                                             President           2017-19

Indian Society of Medical and Paediatric Oncology                                                 President           2009-11

Indain Academy of Paediatrics,PHO Chapter ,Central Zone                                   Coordinator      1997

IMPORTANT POSITIONS HELD-

• Secretary- Ethics committee Batra Hospital & med Res center
• Secretary- Indian Society of Medical & Paediatric Oncology
• Vice president         -Indian Society of Medical & Paediatric Oncology
• Member Executive- Indian Society of Medical and Paediatric Oncology
• Associate Editor, Member Editorial Board-Indian Journal of Medical & Paediatric Oncology
• Coordinator Central Zone & Faculty – National Training Project, Paediatric Haematology Oncology Chapter Indian Academy of Paediatrics
• Associate Editor-Tobacco Control (SAARC EDITION- British Medical Journal)
• Member Executive- National Organization for Tobacco Eradication
• Visiting Professor- Dept. of Chemotherapy, Institute of Oncology, Bishkek, Republic Of Kyrgyzstan
• Member Executive- National Organization for Tobacco Eradication
• Founder Trustee-Cancer Care Trust & Research Foundation
• Resource Person /Advsiory Board- Roche Pharmaceuticals, Novartis, Johnson & Johnson, Bayer Pharma,   Dabur Oncology, Biocon Pharma, Voluntary Health Association of India

PUBLICATIONS

BOOK AND CHAPTERS IN BOOK

1. 2020    Educational Book , American Society of Clinical Oncology- Chapter- Making the best use of resources in Global Cancer Care- Juan Gago, MD, MPH ; Dinesh Pendharkar, MD, PhD ; Chandramauli Tripathi, MBBS ; and Ophira Ginsburg, MSc, MD, FRCPC

2. 2017    Educational Book, American Society of Clinical Oncology-Chapter.Thinking differently in global health in oncology using a diagonal approach: harnessing similarities, improving education, and empowering and alternative oncology workforce. Natalia Rodriguez, Jeannine M Brant, Dinesh Pendharkar, Hectir-Arreola-Ornelas, Afsan Bhadelia, Gilberto de Lima Lopez, Felicia M Knaul 416-425

3. Double refractory myeloma: Management – Chapter in Book-  Haematology Today- A Case Based Approach , Published by Dr M B Agrarwal    2015, pp 447-456

4. Breast cancer in Young women- Co-author Chapter in Book-  Converge Breast cancer Update 2014 (ISBN N0 :978-81-923972-2-1) Published by Purvish Parikh Mumbai 2014, pp187-202
5. Targeted Therapy, Reference book for physicians, 2013,Published by MET
6. Reference Manual for National training project- Practical Paediatric Oncology PHO Chapter, Indian Academy of   Paediatrics   , Associate Editor 1998,

PUBLICATIONS

International Practice changing Publication- Novel and effective management of capecitabine induced hand foot syndrome Proceedings ASCO, volume 23, PP 3308, 2004

1. Pendharkar, D., Nirmal, G., Gupta, N., & Raj, A. (2023). Real-World HbF Status in Sickle Cell Disease from an Endemic Zone. Journal of Pediatrics, Perinatology and Child Health, 07(01). https://doi.org/10.26502/jppch.74050138
2. Pendharkar D and Nirmal G. Hematopoietic Stem Cell Transplantation for Sickle Cell Disease: A Review. . Journal of Pediatrics, Perinatology and Child Health. 7 (2023): 45-54. DOI:10.26502/jppch.74050143
3. Sickle Cell Disease: A Reality Check from A Prevalent Zone In India Dinesh Pendharkar1*, Garima Nirmal2 , Neha Gupta1 , Abhishek Raj1 , J Pediatr Perinatol Child Health 2023 DOI:10.26502/jppch.74050141

4. Pendharkar, D., & Tripathi, C. (2022). Cancer care for the poor-health system augmentation model. Journal of Clinical Oncology, 40(16_suppl), e13514–e13514. https://doi.org/10.1200/JCO.2022.40.16_suppl.e13514
5. Olimova, Z. A., & Pendharkar, D. (2022). Feasibility of next generation sequencing (NGS) from Uzbekistan: A preliminary data analysis. Journal of Clinical Oncology, 40(16_suppl), e14579–e14579. https://doi.org/10.1200/JCO.2022.40.16_suppl.e14579

6. Pendharkar D, Tripathi C. Cancer care system strengthening (Pendharkar model) offers uninterrupted care continuum during COVID19 pandemic. Journal of Clinical Oncology. 2021;39(15_suppl):e13540-e13540. doi:10.1200/JCO.2021.39.15_SUPPL.E13540
7. Pendharkar, D., & Tripathi, C. (2020a). Cancer site distribution in district hospital in central India. Journal of Clinical Oncology, 38(15_suppl). https://doi.org/10.1200/jco.2020.38.15_suppl.e13627
8. Pendharkar, D., & Tripathi, C. (2020b). Implementation science of district cancer care delivery model (Pendharkar model). Journal of Clinical Oncology, 38(15_suppl). https://doi.org/10.1200/jco.2020.38.15_suppl.e19024
9. Pendharkar D. Oncology leadership development using decentralization, task shifting, techno-mentoring        and creation of alternate oncology workforce. Journal of Clinical Oncology. 2019;37(15_suppl):e18043-e18043. doi:10.1200/JCO.2019.37.15_suppl.e18043
10. Tripathi C, Pendharkar D, Saitya BS. Satisfaction survey from an innovative cancer care delivery model (Pendharkar model), creating access at scale: An outcome research. Journal of Clinical Oncology. Published online 2019. doi:10.1200/JCO.2019.37.15_suppl.e18002
11. Khullar P, Pendharkar D, Gupta S, Vatsal S, Dhingra N. Survival estimates for young patients with tongue cancer: An analysis of the SEER database. Journal of Clinical Oncology. 2019;37(15_suppl):e17549-e17549. doi:10.1200/jco.2019.37.15_suppl.e17549
12. D. P, R. S. The virtual tumor board of the future: A review of a promising new technology for better enabling remote clinical collaboration. Anticancer Res. 2018;38(9).
13. Studying chemotherapy toxicity levels in district cancer care delivery model J.Clin Oncol.35, 2017 (suppl:abstr e18003)
14. Drug Approval Process in India, ASCO Daily News 4 May 2016.
15. Innovative healthcare delivery model to expand access and outreach of cancer care services.J.Can Res Ther. 2016, 12:2-5
16. Rural Oncology Mission in central Indian state: report from unique cancer program. Dinesh Pendharkar et al J.Clin Oncol 33:5s,2015 (suppl; abstr e 175526)
17. Incidence and survival of gall bladder cancer over three decades :SEER database study.  Co-author-J.Clin Oncol 33:5s, 2015 (suppl;abstr  e 17651)
18. Survival Trends Among Very Elderly Patients with Advanced Diffuse Large B-Cell Lymphoma - a Population Based Study. 2640.Popster presentation. American Society of Haematology 2014, Blood 2014. (Binay Shah, B Ghimire, D.Pendharkar)
19. Molecular Biology of Lung Cancer—A Review- Indian Journal of Surgical Oncology,v 4 No 2, 2013
20. Safety and feasibility of outpatient TPX regimen. e16057. J Clin Oncol 30, 2012 (suppl; abstr e16057)
21. Epidemiology of cancer in Afghanistan , Journal of Clinical Oncology, v,27, 2009
22. Treatment continuum and not reinstitution should be the management strategy in non small cell lung                  cancer.
23. Journal of Clinical Oncology, v. 26 No. 15S,abst 18500, 2008
24. Neutrophil response kinetics after G-CSF and Peg-CSF usage post chemotherapy.
25. Journal of Clinical Oncology V.26 No. 15S abst 20708, 2008                     
26. Feasibility of combining humanized anti-epidermal growth factor receptor monoclonal antibody                                                   h-R3(nimotuzumab) with chemotherapy- A study of toxicity profile and tolerance. Journal of Clinical Oncology Vol. 25, No. 18S , abstract 14151, 2007
27. Off –pump coronary artery bypass grafting in a polycythemic patient-case report and review of literature.Dheeraj Arora,Rajiv Juneja, Dinesh pendarkar, yatin Mehta Naresh Trehan. Annals of cardiac Anaesthesia 02/2007,:10 (1)54-7
28. Uterine choriocarcinoma in a postmenopausal woman. U.Mukherjee, V.Thakur, D.Katiyar, Hari K Goyal, D.Pendharkar. Medical oncology 2006,V.23, isuue2, pp301-303
29. Loading dose ibandronate in acute pain management of metastatic bone disease. Proceedings ASCO , 2006
30. Cancer in India.ASCO News & Forum, p. 49, Jan 2006
31. Novel and effective management of capecitabine induced hand foot syndrome Proccedings ASCO, volume 23, PP 3308, 2004
32. Erythropoetin (EPO) in Indian population- a case for review. D.Pendharkar et al Blood, v .100, No. 11, abstr.3530, 2002
33. Carcinoma lung-patterns of presentation. Walia J, D.Pendharkar et al; International Journal of Cancer, Suppl 13 (2002)  P.124, p.181, 2002
34. Cancer diagnosis and management- changed prospects;  Batra Hospital New Letter, Oct 2002
35. Indian National Training Project Practical Pediatric Oncology(INTPPO):2nd National Teachers meeting, consensus report (Co-author); SIOP, Port,Sept, 2002; Medical & Pediatric Oncology 2002, 37(3) 189 abstr. Hemoglobin levels in patients undergoing radiation-An Indian data; D.Pendharkar et al; American Society of Clinical Oncology-Program Proceedings; Volume 20,Abstract 2965, 2001
36. Indian National Training Project Practical Pediatric Oncology (Co-author); Medical & Pediatric Oncology 2001, 35 (3), 163 abstr.
37. Effective short term premedication for paclitaxel infusion; Abstract-XI thBiennial Conference of the Indian Society of Medical & paediatric Oncology Jan 2001, Hyderabad
38. Herceptin- a review. Breast cancer in the new millennium-Conference Nagpur 17-20 Feb, 2000
39. Reference Manual for National training project- Practical Paediatric Oncology; PHO Chapter, Indian Academy of   Paediatrics   , Associate Editor1998,
40. Autologous peripheral stem cell transplant in non-Hodgkin’s lymphoma. Dinesh Pendharkar JAPI, 1998 vol 46, No. 9, p.829
41. Retinoblastoma; Chapter in Reference Manual for National training Project; Indian Academy of Paeditatrics-1998 , 2 nd Edition 2003
42. Tropical Oncology- A new concept; Abstarct –International cancer Congress Brazil 1998
43. Cancer Education-The most effective way of fighting cancer (Editorial)  Indian J.of Med Paed Oncology 1997 vol. 18, 31-32         
44. Recent advances in bone marrow transplantation-stem cell transplantation; Dinesh Pendharkar  45 th Annual Conference of the Indian Medical association, M.P. State Branch; October 18-19-1997
45. Tamoxifen- why , when and How long ?; Dinesh Pendharkar; Proceedings Biennnial Conference of the Indian Society of Medical & Paediatric; Oncology , Feb. 1997                                                                            
46. Lactate Dehydrogenase and Its Isoenzymes in Serum From patients With Neoplastic Disorders. Bhawna Nigam, S.P. Joshi, D. Pendharkar , Rajesh Chavan, Ind .J.Med.& Ped Oncol.  1996 Vol. 17: 178-184.
47. Some Biochemical Markers in Various Neoplasms: A Multivariate Analysis; Bhawna Nigam, S.P.Joshi, Seema Nagar ,Rajesh Chawan, & D. Pendharkar Indian Journal of Clinical Biochemistry 1996, 11(2), 124-128.
48. A New Philosophy of Anti Tobacco Campaign; D.Pendharkar et al.; Proceedings of  The 12th Asia Pacific Cancer Conference; Singapore , Oct 1995 , p. 618
49. Phase II feasibility study of Ifosphamide/mesna and 5-FU in recurrent advanced squamous cell carcinoma; D.Pendharkar et al.; Proceedings of The 12th Asia Pacific Cancer Conference Singapore , Oct 1995  , page 276

50. Cost effectiveness in mammography; A.Vohra, SS Nayyar, D.Pendharkar; Proceedings of the 12th Asia Pacific cancer Conference; Singapore, Oct 1995, p. 622
51. Anti-Tobacco Campaign Organizational Aspects; D.Pendharkar et al.; Proceedings of the XVI International Cancer Congress; N.Delhi. Nov 1994  , OPPR 6-10, p. 106.
52. Cervical cytology programme in Indian context; SS Nayyar, D. Pendharkar, V.Bhandari et al. Proceeedings of the 16th International Cancer Congress N.Delhi, Nov 1994,  PSPR 4-01, p. 438    
53. Testicular Tumors- “ Towards a Cure’ D.Pendharkar; Bombay Hospital Journal 1994, vol. 6 No.3,103-108.
54. Anti-Tobacco Campaign- Organizational Aspects. D.Pendharkar, SS Nayyar, Proceedings Of the 16th International Cancer Congress, 1994, 749-752.
55. Cancer Chemotherapy –Present Perspectives Journal of The Choithram Hospital & Research Center Vol. 1, No2 65-66. 1989
56. Chemotherapy of Lymphosarcoma (Non-Hodgkin’s Lymphoma) in the USSR G. Kruglova & D. Pendharkar Sov. Med. Rev. F. Oncol., Vol 2, 1987 pp 117-129.
57. Role of achieving a repeat complete remission. Proceedings of the 14th International cancer Congress Budapest Hungary 1986, abstract, 1691.
58. Patterns of Relapse After radiotherapy and Its Management in Non-Hodgkin’s LymphomaGV Kruglova, DYR Pendharkar;Teapeutichiski Archiv, 1985, 5
59. Recurrences of the Lymphosarcoma of The Throat Ring After Radiation Therapy. GV Kruglova, DYR Pendharkar Meditsinskaya Radiologia, 1984, 1
60. Chemotherapy (CT) of Non-Hodgkin’s Lymphoma (NHL); GV Kruglova,RA Abyldaev, D.Y.R. Pendharkar
61. Proceedings of the Second International Conference on Malignant Lymphoma Lugano, Switzerland, June , 1984 (T-91)
62. Asparaginase (ASP) in the treatment of Non- Hodgkin’s Lymphoma (NHL) DYR Pendharkar, RA Abdyldaev, GV Kruglova Proceedings of the Second International Conference on Malignant Lymphoma
63. Lugano Switzerland, June 1984, (P-98) Non-Hodgkin’s Lymphoma- Clinical relevance Of The World Health Organization Classification. D.Pendharkar, GV Kruglova Proceedings of the 13 Th International Congress of Chemotherapy, Vienna,1983, Part 239.
64. Results Of Polychemotherapy of Various Lymphosarcomas According To The WHOClassification Gematologia I Transfusiologia, 1983, 4
65. Second malignancy In Patients’ With Hodgkin’s Disease                                                                                                                                                                                                                                                                                           NN Pokrovskaya, NF Vasygova, D.Y Pendharkar et al    Voprosi Onkologi, 1983, 9
66. Management of Relapsing Waldeyer’s ring Lymphom; Zdravoochraneniye Kirgizii,  1983,  July- August

CURRENT PROJECT

Theme: Empowering Alternate Workforce in Oncology (Published Education Book ASCO 2017)

Description: We have made tremendous progress in cancer research. The treatment will be its worth only if it reaches all people in need. Due to multiple social ,financial, logistic reasons only very few patients start treatment, continue treatment. As a result we do not achieve our goals of cure, longer survival or better quality of  life. To improve this a healthcare delivery model has been designed and effectively implemented in a  7 States (Madhya Pradesh, Odisha, Himachal Pradesh, Rajasthan, Bihar, UP, Gujarat,Chhattisgarg) in India This could be good model for cancer care delivery for countries with less human resources. Model established in 176 districts of India with coverage to 300 million population, presented at ASCO annual meeting in 2017. Dr Susan Miesfeldt MD from Maine Medical Center reported in ASCO Connection on 19 th May 2015  about this programme , as serving these goals

Other Activities

International Oncology activities

Cancer activities with International Cancer Institute , Kenya in various counties of Africa-Ongoing

Reviewing and assisting Cancer care and Sickle cell care in Burundi

• Cancer Camp-Kabul Afghanistan: One of the longest and best attended camp where more than two hundred patients were seen. The lecture at Indira Gandhi Institute of Child Health was well received. The live phone in programme on local TV channel- TOLO was as well a great opportunity to increase awareness about cancer.
• Cancer Camp in Kenya, Mombasa- One camp in Memon Hospital in 2012 and four camps in Mombasa hospital, Bomu Hospital, Memon Hospital, Bohra Hospital Mombasa 18,19 Jan 2013, Other 2019,20,21
• Cancer camps in County hospitals of Kenya- Meru, Kaspabet, Voi,
• Cancer camps in Kyrghyzstan, Uzbekistan(Andijan ,Jizzak, Bokhara, Tashkent,)
• Multidisciplinary Cancer Management Courses (ASCO)- Nepal, Kenya, Armenia, Bhutan
• Euro-Asian Federation Of Oncology- Faculty Meeting, Kazakhstan, Moscow, St Petersburg

Professional Educational Activities

• Organised multiple educational activities at national and international level.
• Involved as faculty in innumerable oncology activities
• Specially conducting multiple activities for members of Indian Medical Association all across the country

Establishing Speciality of Medical Oncology- Cancer Chemotherapy  in  Central India: Cancer Chemotherapy as an independent branch is lagging behind as other specialist cover up and doctors were not coming to take up this speciality. But this branch forms the mainstay of cancer management. Right from 1981 when I first approach for house job in Tata Hospital I was confident in taking up this speciality as I had received formal orientation during my studies and training in Europe. I was one of the first to take up this branch individually in this country and was one of the very first to take it up outside the setting of cancer hospital. Even today the total number of chemotherapists practicing exclusive this branch does not exceed 50. Through professional and public education it is a well-recognized branch in central India. I had been respected and privileged to be member of National Society and now even its Honorary Secretary.

Cancer Care Trust: The project was conceived by group of doctors and social workers and had taken my major time. Through public educational ideology CCT was able to create a public image and establish one of its kind Cancer Detection and Prevention Center and Cancer Care Hospital. For the first time a concept of well designed cancer detection and prevention center was put in to practice. From no money the project has gone high to eight crore rupees.

PAP Cytology Programme: Encouraged with meeting at ICMR I decided to launch PAP cytology programme with aim to educate doctors and manufacture spatula. Through personal efforts I convinced every lady doctor to take PAP smear and organized for its reporting free. With help of local industrialist made plastic spatula, which later on with support of CCT translated into real spatula, now in use. But I was able to generate the awareness about PAP cytology and the number of these investigations, which was in tens, has gone to thousands per anum. This will lead to early detection of cervical cancer.

Anti -Tobacco -Movement- Tobacco is one of the biggest killers. It causes diseases, which can be prevented. Encouraged with presentations at Budapest and Hamburg Conference, I decided to study and use full campaign strategies. It was this time I read and planned A Total Campaign – campaign which tried to cover every aspect of mass education and planning. The idea was to educate masses and bring together social organizations and people. Within a span of few years a most well designed and planned campaign was given to the town, which has left mark not only in Indore and MP, but whole of the country. Its success was well appreciated nationally and internationally was able to make a dent in National Anti Tobacco Campaign and was even given charge of planning National campaign. I was made member of the executive and helped in bringing closer all groups working on this issue. Organised painting competitions, poster competitions, mass rallies, published stickers, leaflets, music campaigns, and many other activities.

The data had been presented at various meetings and has been recognized as one the most planned campaigns. In one go it had included – hoarding, leaflets, public education stickers, posters, lectures, rallies, painting competitions, slogan competitions. These all activities were planned together. And the impact was phenomenal. Generally organizations hold individual activity. This gave to conclusion that multifarious activity in short span of time creates more impact than individual over long time.

This also helped in creating public image for Cancer Care Trust, which later translated in to huge donations.

Public Education in Cancer: Public education is an important aspect of medicine. My interest had been in cancer education .I had been regularly giving public lectures on aspects of early diagnosis, cancer related checkup guidelines, reducing risk of cancer. Various leaflets have been prepared from time to time related to this.

Tsunami Relief Work: Participated as tsunami relief worker in Little Hutbay Area of Andaman Nicobar Islands in Jan 2005 right after the tsunami struck this area. One of the first person to reach and offer medical and socials relief with NGO- VHAI. Experience published in Niramayam , Batra Hospital and acknowledged by “Outlook”.

Dr Dinesh Pendharkar

SYNOPSIS

Top Medical Practitioner Medical Oncology, Haemato-oncology, Bone Marrow Transplantation /Director Cancer Institute/ Researcher/ Consultant/ Visiting Professor

Offering four decades of experience in multi-dimensional roles in supporting medical oncology & facilitating the cause to provide free medical service & support across rural India for cancer treatment

Dedicated and experienced Doctor of Oncology, graduated in 1984, with more than 35 years of oncology experience

• Past President of Indian Society of Oncology/ Past President of Indian Society of Medical And Paediatric Oncology
• Director Odisha Cancer Care Foundation
• Board Member  Acharya Harihar Post Graduate Institute of Cancer, Cuttack
• Consultant Medical Oncology for National Republican Institute of Oncology, Tashkent, Uzbekistan, Visiting Professor of Medical State University Andijan, Khwarezm, Uzbekistan, International Cancer Institute- Eldoret, Kenya.
• Possess insight into the domains of medical Oncology and capable of establishing new milestones through hands-on research exposure.
• Presently working on a healthcare delivery model, designed and effectively implemented in a eight States (Madhya Pradesh, Odisha, Himachal Pradesh, Rajasthan, UP, Bihar, Gujarat, Chhattisgarh ) of India to reach to our goal of cure, longer survival or better quality of  life.
• Trained nearly 200 physicians from the district.
• Cancer care units initiated in government district hospitals of eight states, as District Cancer Care Programme, more than 150 functioning- all districts Odisha, Rajasthan, MP, Chhattisgarh and few in other states.
• Proven expertise in planning, designing and execution of- unique healthcare delivery model. Acknowledged for Empowering Alternate Workforce in Oncology.
• Credentials of initiating and managing the health, education projects including undertaking research work & networking with different stakeholders like businesses, community, NGOs & Government Organization.
• Worked as a Consultant to different cancer support organizations for programme planning, monitoring and evaluation, and capacity building especially in the field of delivering healthcare support for cancer patients in under privileged section of society.
• Expertise in Participatory programme planning, implementation, monitoring and evaluation of integrated community development projects using different tools and methods
• Professional record demonstrates successful and enriched association with renowned educational / research institutes in India
• Efficient contribution in editorial activities, refereeing contribution to publishing & various research works.
• Superior multitasking talents, with the ability to manage multiple high-priority assignments and develop solutions to challenging medical enquiries.
• Strong team leader with proven track record of consistently raising efficiency levels of civil societies, community and self-help groups, to balance high level skill with maximum productivity
• Involved in training of healthcare professionals in Oncology through ICI Kenya, for physicians in Africa